American Lung Association Empowers and Educates During Pulmonary Fibrosis Awareness Month with Vital Resources

This September, the American Lung Association is dedicating its efforts to raising awareness about pulmonary fibrosis (PF) as part of Pulmonary Fibrosis Awareness Month. With more than 200 different types of pulmonary fibrosis, the American Lung Association is committed to informing the public, providing vital resources and highlighting the signs and symptoms of this challenging lung disease.

Pulmonary fibrosis is a subset of interstitial lung disease, characterized by the development of scar tissue in the lungs, impairing their function over time. The diversity of over 200 types of pulmonary fibrosis poses a significant challenge, with the most common type being idiopathic pulmonary fibrosis (IPF), where the cause remains unknown. Each year, around 50,000 new cases of IPF are diagnosed, primarily affecting individuals aged 50 to 70 years. While more prevalent in men, the incidence of IPF in women is steadily increasing, underscoring the need for heightened awareness, education, and resources for all individuals.

"As we observe Pulmonary Fibrosis Awareness Month, we are committed to empowering patients, caregivers and the general public with accurate information about this complex lung disease," said Harold Wimmer, President and CEO of the American Lung Association. "Our goal is to promote early detection, offer essential resources and foster a sense of community through our Patient & Caregiver Network."

Currently, no cure exists for PF, but there are various treatment options available to enhance the quality of life for those living with the disease. Medications, oxygen therapy and pulmonary rehabilitation are among the treatments employed, with severe cases possibly requiring a lung transplant.

During Pulmonary Fibrosis Awareness Month, the Lung Association is offering educational webinars tailored to patients and caregivers. These webinars aim to improve the understanding of the signs and symptoms of PF, equipping individuals with knowledge that can lead to earlier diagnosis and improved management.

Furthermore, the Lung Association's Patient & Caregiver Network stands as a crucial resource for individuals and families affected by PF and other lung diseases. This nationwide community serves as a hub for essential support, education, and access to emerging research such as clinical trials. By visiting Lung.org/pcn, people with interstitial lung diseases and their loved ones can find a strong support system to navigate their journey.

To learn more about pulmonary fibrosis and access valuable resources, please visit Lung.org/PF.